Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis by Tsukifuji, R et al.
Neoplasms invade and metastasize degrading extracellular matrix
(ECM), and therefore a large number of proteases involved in the
invasion process have been extensively studied in order to under-
stand tumour behaviour. Matrix metalloproteinases (MMPs)
constitute a gene family of highly homologous enzymes capable of
degrading ECM components, and play crucial roles in tumour
progression (Liotta et al, 1991). MMP-1 (interstitial collagenase)
degrades types I, II and III collagens, and MMP-2 (72-kDa type IV
collagenase) degrades gelatin, types IV, V, VII and X collagens.
MMP-3 (stromelysin-1) with a broad substrate specificity,
degrades proteoglycans, laminin, fibronectin, gelatin and types III,
IV, V and IX collagens (Mauviel et al, 1993). In skin cancer, the
expression of MMP-1 and MMP-2 mRNAs has been revealed in
basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)
(Gray et al, 1992; Pyke et al, 1992). Recent studies have demon-
strated that MMP-3 mRNA is expressed in BCC (Majmudar et al,
1994; Tsukifuji et al, 1997).
Although previous studies have suggested that MMP expression
is related to tumour invasion (Matrisian et al, 1991; Gray et al,
1992; Pyke et al, 1992; Tsukifuji et al, 1997), the regulatory mech-
anism for MMPs in tumour tissue has been largely unknown. In
tumour progression, the production and activity of MMPs can be
changed by cytokines, tissue inhibitors of matrix metallopro-
teinase (TIMPs) and other proteases derived from tumour cells,
fibroblasts and/or inflammatory cells (Liotta et al, 1991; Mauviel
et al, 1993). An enormous number of factors should be involved in
the extensive ECM degradation of malignant tumour tissue. It is
therefore conceivable that the study of carcinoma at early stage or
in situ is valuable for understanding the essential roles of MMPs in
the multiple steps of tumour progression.
In the present study, we investigated the expression of MMP-1,
-2 and -3 in skin cancer, focusing on the early events occurring in
invasive tumours. In situ hybridization can identify the cells
responsible for the protein and detect the mRNA before its local
accumulation. SCC and actinic keratosis (AK), a precancerous
condition of SCC, were examined in this study, and the roles of
MMPs during tumour progression were discussed.
MATERIALS AND METHODS
Tissue samples
Tissue specimens of skin tumours (15 SCCs, six AKs associated
with SCC and 16 AKs) were obtained by surgical resection at
Chiba University Hospital. The specimens were fixed in 10%
buffered formalin immediately after the operation and embedded
in paraffin. Four-micrometer tissue sections were mounted on
aminoacyl silane-coated glass slides, dried overnight at 42°C and
immediately used for in situ hybridization and immunohisto-
chemical examination. The sections stained with haematoxylin
and eosin were examined independently by two or more experi-
enced pathologists and dermatologists for histological diagnosis.
The patients with SCC were staged according to UICC TNM
classification (Sobin et al, 1997).
RNA probe preparation
RNA probe preparation for MMP-1 and MMP-3 has been
described previously (Tsukifuji et al, 1997). A template fragment
for MMP-2 was obtained from human fibroblast MMP-2 cDNA
(Collier et al, 1988), using the restriction enzyme. Each fragment
(the 1016-bp MMP-1 fragment extending from nucleotide 273 to
1289, the MMP-2 fragment from 1353 to 1747, and the 573-bp
MMP-3 fragment from 828 to 1401) was subcloned into pGEM 7Z
vector (Promega, Madison, WI, USA). Labelled probes were
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merase using digoxigenin-labelled uridine triphosphate as
substrate (Digoxigenin RNA labelling mixture, Boehringer
Mannheim, Indianapolis, IN, USA).
In-situ hybridization
Details of the method have been reported previously (Tsukifuji et
al, 1997). Deparaffinized sections were treated with proteinase K
(4 mg ml–1) at 37°C for 20 min, followed by rinsing in phosphate-
buttered saline (PBS). Then the specimens were incubated with
chondroitin ABC lyase, 0.02 units ml–1 (Seikagaku Kogyo, Tokyo,
Japan), in buffer solution (0.1 M Tris–HC1 pH 8.0, 0.03 M sodium
acetate, 0.05% bovine serum albumin) at 37°C for 30 min. After
rinsing in PBS, the slides were refixed in 4% paraformaldehyde
for 20 min, and then dipped in 2 mg ml–1 glycine for 15 min and
0.2 N hydrochloric acid for 10 min. Immediately after this pretreat-
ment, the sections were prehybridized in 50% formamide and 2 ´
standard saline citrate at room temperature for 1 h. They were then
covered with the antisense or sense RNA probe in hybridization
buffer (50% formamide, 10% dextran sulphate, 1 ´ Denhardt’s
solution, 200 mg ml–1 yeast tRNA, 600 mM sodium chloride, 1 mM
EDTA, 0.25% sodium dodecyl sulphate (SDS), 10 mM Tris–HCl
pH 7.6) and incubated at 50°C for 18 h in a humidified chamber.
The RNA probes of MMP-1, MMP-2 and MMP-3 were used at
concentrations of 400, 700 and 700 ng ml–1 respectively. After
hybridization, the slides were washed under stringent conditions
and treated with RNAase to remove the unhybridized probes. The
sections were incubated with 1.5% blocking reagent and anti-
digoxigenin antibody conjugated with alkaline phosphatase,
1: 500 (Boehringer Mannheim, Indianapolis, IN, USA) for 1 h at
room temperature. After rinsing, labelling was visualized by
colour products of Fast Red (BioGenex, San Ramon, CA, USA).
Counterstaining was done with methyl green.
The evaluation was based on the mean number of labelled cells
per high power field (hpf). A minimum of 8 hpfs and up to 15 hpfs
were counted using a ´10 eyepiece and a ´ 40 objective lens and
scored as follows; +++ > 20 cells: ++, 2–20 cells per hpf; +, 0.2–2
cells per hpf; –, < 0.2 cells per hpf.
Statistical methods
The semi-quantitative scores of in situ hybridization were evalu-
ated using Kruskal–Wallis test or Pearson’s correlation coefficient,
and P < 0.05 was considered significant.
RESULTS
The results of semi-quantitative evaluation of in situ hybridization
are summarized in Table 1.
The expression of MMP-1, -2 and -3 mRNAs in SCC
The expression of MMP-1 mRNA was detected in all SCC samples.
Distinct signals for MMP-1 mRNA were observed in tumour cells
and spindle-shaped cells of the stroma (Figure 1A, B). The tumour
cells expressing MMP-1 mRNA were mainly located at the invasive
area of the neoplasm. Fibroblast-like cells with the hybridization
signals were observed mostly around the tumour nests. Generally,
MMP-1 mRNA appeared to be more abundant in stromal cells than
in tumour cells. Superficially invasive tumours in the early stage
already demonstrated moderate signals for MMP-1, and those of
deeply invasive ones were remarkably pronounced (Table 1).
The expression of MMP-3 mRNA was detected in 11 of the 15
SCCs. Fibroblast-like cells among the tumour nests and a few
neoplastic cells were responsible for the hybridization signals for
MMP-3 (Figure 1 C, D).
The expression of MMP-2 mRNA was detected to various
degrees in fibroblast-like cells of the stroma in all cases, but was
not detected in tumour cells (Table 1). The hybridization signals
for MMP-2 were generally weak and scattered throughout the
stroma (Figure 1E, F).
The expression of each MMP tended to increase according to
the tumour progression but the differences were not significant
(P > 0.1) in the tumour stages (I, II and III). The signals for
MMP-3 were localized at limited areas, where abundant MMP-1
mRNA was usually observed (Figure 2A, B). MMP-3-positive
cells correlated with MMP-1-positive ones (P = 0.03) although the
former were not as many as the latter (Table 1). On the other hand,
the expression of MMP-2 did not appear to have any relation-
ship with those of MMP-1 (P = 0.20) and MMP-3 (P = 0.69)
(Figure 1 G–I).
Normal skin demonstrated no distinct signals for the MMP
mRNAs examined. For a control study, the signals in serial sections
treated with sense probes or RNAase were always compared at the
same time. Hybridization with the sense probes showed no specific
activity (Figure 1B, D, F) and RNAase treatment before hybridiza-
tion removed positive reactions to antisense probes.
The expression of MMP-1 mRNA in AK
MMP-1 mRNA was detected in four of the 16 AK specimens. The
signals for MMP-1 were found at a minority of basal keratinocytes
showing atypical nuclei and disorderly arrangement. Stromal cells
in a dense inflammatory infiltrate were also positive for the
MMP-1 probe (Figure 2A, B). In another case, MMP-1 mRNA
was expressed by the basal and suprabasal keratinocytes in the
epidermis proliferating into the dermis (Figure 2C, D). No distinct
signals for MMP-2 and MMP-3 mRNAs were detected in these
areas. Secondary changes such as erosion or ulceration were not
observed near the positive signals. In AKs the signals for MMP-1
were detected in the anaplastic keratinocytes of hypertrophic
epidermis with a dense inflammatory infiltrate in the dermis.
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Table 1
Case No. MMP-1 MMP-3 MMP-2 TNM
TS TS S
stage
1+ + – – + + I
2 + ++ – – ++ I
3 + ++ + + ++ I
4+ + + + + + + + I
5 + ++ – – ++ I
6+ + + + + + + I
7 ++ +++ – + + I
8 + ++ – – +++ II
9 + ++ + + + II
10 ++ ++ + + ++ II
1 1 + + ++ ++ + I I I
12 + +++ + ++ ++ III
13 +++ +++ – ++ +++ III
14 +++ +++ + +++ +++ III
15 ++ +++ – ++ +++ IV
T: tumour cells; S: stromal cells.MMPs in SCC and AK 1089
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Figure 1 The expression of matrix metalloproteinases in squamous cell carcinoma by in situ hybridization. The targeted mRNAs are demonstrated by red
products. Specific signals for MMP-1 antisense probe are observed in tumour cells and spindle-shaped cells of the stroma (A). MMP-1 sense probe shows no
specific hybridization signals (B). Signals for MMP-3 antisense probe are found in stromal cells and a few tumour cells (arrowheads) (C). No signals for MMP-3
sense probe (D). The positive cells for MMP-2 antisense probe are scattered throughout the stroma associated with the tumour nests (arrowheads) (E) and
these cells are negative for MMP-2 sense probe (F). T: tumour; S: stroma. In serial sections, abundant signals for MMP-1 (G) and moderate for MMP-3 (H) are
observed while faint signals for MMP-2 are found in the stromal cells (I). Scale bars = 20 mmThe lesions of carcinoma in-situ found adjacent to invasive SCCs
were also examined for MMP expression. All such cases examined
in the study were found at sun-exposed sites in the elderly and
considered to be AK. In four of six AKs accompanied by SCC,
expression of MMP-1 mRNA was observed in the keratinocytes and
stromal cells. Immunohistochemical staining for MMPs in AK was
so weak that the localization of each MMP was not determined.
DISCUSSION
The most interesting finding in the present study is that MMP-1
mRNA was expressed in AK as well as invasive tumours. In several
specimens of AKs and most of AKs associated with SCC, the distinct
signals for MMP-1 mRNA were observed in the keratinocytes pro-
liferating downwards. Since there was no erosion or ulceration in the
vicinity of MMP-1-positive cells in the AK specimens, MMP-1
mRNA was not induced by acute phase reactions of the wound
healing process (Inoue et al, 1995). It has been reported that the
activity of MMP-1 is required for keratinocyte migration on a type I
collagen matrix (Pilcher et al, 1997). It is possible that atypical
keratinocytes expressing MMP-1 in AK could be involved in cell
migration associated with the tumour progression.
The expression of MMP-1 mRNA was observed extensively in
tumour and stromal cells of SCC, consistent with the previous
report (Gray et al, 1992). In basal cell carcinoma (BCC), which is
rarely metastatic, MMP-1 mRNA was expressed in stromal cells
and detected in relatively large tumours of nodulo-ulcerative type,
but not in small tumours of superficial type (Tsukifuji et al, 1997).
On the contrary, MMP-1 was produced by tumour and stromal cells
from the early stage of SCC and carcinoma in situ. These different
patterns of MMP-1 expression might explain the differences in
invasive and metastatic behaviour between SCC and BCC.
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Figure 2 Hybridization with MMP-1 antisense probe (A and C) and sense probe (B and D) in actinic keratosis. MMP-1 mRNA is expressed by the anaplastic
cells in the basal layer. Superficial clefts and lacunae are present as a result of secondary acantholysis. The positive signals are also observed in a small
number of stromal cells (A). No signals for the sense probe (B). MMP-1 mRNA is expressed by the keratinocytes of the epidermis extending downwards (C).
No signals for the sense probe (D). Scale bars = 20 mmAlthough it was suggested that MMP-3 could be significantly
involved in the progression of SCC (Matrisian et al, 1991), the
expression of MMP-3 mRNA was difficult to detect in SCC by in
situ hybridization (Muller et al, 1993). Our study distinctly indi-
cated that MMP-3 mRNA was expressed in SCC specimens which
revealed MMP-1 mRNA at high levels. Its localization pattern
suggests that its expression may be linked, to some degree, with
that of MMP-1. Since MMP-3 mRNA was not detected in AK,
MMP-3 seemed to be induced subsequently to MMP-1 during
tumour invasion. MMP-1 and MMP-3 promoters contain a 12-O-
tetradecanoyl-phorbol-13 acetate (TPA)-responsive element that
binds the transcription factor AP-1 (Angel et al, 1987), and the two
enzymes may be regulated by similar activating mechanisms.
The expression of MMP-2 mRNA did not correlate well with
the SCC stages. MMP-2 mRNA was expressed throughout the
stroma around the tumour mass, and this did not suggest a close
interaction between tumour and stromal cells. However, our
immunohistochemical examination demonstrated that MMP-2
protein appeared to be concentrated at the interface between the
tumour mass and stroma (data not shown). As MMP-2 is supposed
to be activated at cell surface (Sato et al, 1994), the localization of
MMP-2 protein is an interesting issue in the regulation of MMPs.
As for the degradation of type IV collagen, we also searched
MMP-9 gene expression, but it was undetectable in tumour cells or
stromal cells. In SCC, MMP-9 mRNA seems to be expressed at low
levels in small populations of tumour cells (Juarez et al, 1993), and
possibly stromal cells (Ståhle-Bäckdahl et al, 1993). High levels of
MMP-9 gene expression have been reported in ovarian tumours
(Naylor et al, 1994), brain tumours (Nakagawa et al, 1994) and
pancreatic tumours, while MMP-1 and MMP-3 were not detected
in pancreatic tumours (Gress et al, 1995). In breast carcinoma
tissue, MMP-1 was especially abundant in scirrhous carcinoma,
containing great amounts of interstitial collagen, compared to
papillotubular and solid-tubular carcinoma by immunohistochem-
ical examination (Iwata et al, 1996). These reports suggest that the
diversity of MMP gene expression in neoplasms may be related to
the components of tumour-associated stroma as well as the origin
and invasive behaviour of tumour cells.
Since MMP-3 can activate MMP-1 (Suzuki et al, 1990), its
production would enhance tumour invasion into the connective
tissue containing abundant interstitial collagen. It was recently
reported that skin tumours arising in mice deficient of c-fos, a
member of the AP-1 family, failed to undergo malignant conver-
sion, and neither MMP-1 nor MMP-3 was induced (Saez et al,
1995). It is interesting and worthy of further investigation to try to
determine how malignant tumour transformation is related to
ECM-degrading capacity, including the expression of MMP-1 and
MMP-3 in skin tumours.
Taken together, our study indicated that MMP-1, -2 and -3
showed different localization patterns in SCC. Abundant MMP-1
mRNA was detected in SCC, and moreover, it was expressed
frequently in AK associated with SCC and sometimes in AK. Its
expression in AK might be one of the markers for more advanced
dysplastic states, progressing to SCC.
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